Minimal Invasive Surgery for Intrahepatic Cholangiocarcinoma

초록

Intrahepatic cholangiocarcinoma (iCCA) is a rare but increasingly prevalent malignancy with poor prognosis and limited treatment options. Surgical resection remains the only potentially curative modality. While open liver resection (OLR) has been the standard approach, the role of minimally invasive surgery (MIS)?including laparoscopic and robotic techniques?has been actively explored in recent years. Several retrospective studies have reported that MIS for iCCA, when performed in selected patients, is associated with comparable oncologic outcomes to OLR, including overall survival and recurrence-free survival. Moreover, MIS has demonstrated potential advantages in terms of reduced blood loss, shorter hospital stay, and lower postoperative morbidity. Despite these benefits, concerns remain regarding technical feasibility, particularly in cases requiring major hepatectomy or lymph node dissection. This presentation will provide an overview of the current evidence and clinical considerations for MIS in the treatment of iCCA. Key aspects include patient selection, operative technique, and perioperative outcomes, as well as the evolving role of MIS in complex liver resections. By examining both laparoscopic and robotic approaches, this session aims to clarify the indications and limitations of MIS and to outline future directions for its safe and effective integration into iCCA surgical management.